Egypt Ivermectin-based study results on COVID-19 patients!
Back in May 2020, TrialSite announced the study titled A Pilot Clinical Trial led by Egypt’s Mansoura University, located in the middle of the Nile Delta region. A highly ranked academic medical research center within this Middle East nation, a team of investigators there led by two doctors and faculty of medicine professors, sought to test whether the combination of Nitazoxanide, Ribavirin, zinc and Ivermectin clears SARS-CoV-2, the virus behind COVID-19. With results now published in the peer reviewed Journal of Medical Virology, the team has an answer.